CNO Financial Group, Inc.
CNO- Exchange
- NYSE
- Industry
- Accident & Health Insurance
- SEC CIK
- 0001224608
In the last 90 days, CNO Financial Group, Inc. insiders filed 0 open-market purchases and 5 sales; 400 institutions reported holding it in 13F filings for Q3 2026, worth $4.64B in total; no superinvestor holds it.
Other share classesCNO.PA
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 8, 2026, 10:42 PM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 5, 2026 | Feb 6, 2025 | Feb 6, 2024 | Feb 7, 2023 | Feb 8, 2022 |
| Revenue | $4.49B | $4.45B | $4.15B | $3.58B | $4.12B |
| Operating income | $553.2M | $550.8M | $459.5M | $357.1M | $470.6M |
| Interest expense | $230.9M | $254.4M | $238.6M | $137.0M | $95.4M |
| Income tax | $64.1M | $114.3M | $80.3M | $120.5M | $126.7M |
| Net income | $229.3M | $404.0M | $276.5M | $396.8M | $441.0M |
| EPS, basic | $2.35 | $3.81 | $2.44 | $3.43 | $3.43 |
| EPS, diluted | $2.30 | $3.74 | $2.40 | $3.37 | $3.36 |
| Weighted shares, basic | 97.8M | 106.1M | 113.3M | 115.7M | 128.4M |
| Weighted shares, diluted | 99.8M | 108.1M | 115.1M | 117.7M | 131.1M |
| Margins and growth | |||||
| Operating margin | 12.3% | 12.4% | 11.1% | 10.0% | 11.4% |
| Net margin | 5.1% | 9.1% | 6.7% | 11.1% | 10.7% |
| Revenue growth, year over year | +0.9% | +7.3% | +15.9% | −13.2% | +7.9% |
| Net income growth, year over year | −43.2% | +46.1% | −30.3% | −10.0% | +46.1% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 5, 2026 | Feb 6, 2025 | Feb 6, 2024 | Feb 7, 2023 | Feb 8, 2022 |
| Total assets | $38.8B | $37.9B | $35.1B | $33.3B | $36.2B |
| Total liabilities | $36.2B | $35.4B | $32.9B | $31.9B | $30.9B |
| Shareholders' equity | $2.64B | $2.50B | $2.22B | $1.40B | $5.26B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 5, 2026 | Feb 6, 2025 | Feb 6, 2024 | Feb 7, 2023 | Feb 8, 2022 |
| Operating cash flow | $675.7M | $627.7M | $582.9M | $495.4M | $598.3M |
| Depreciation and amortization | $318.5M | $292.4M | $267.4M | $345.3M | $319.5M |
| Dividends paid | $66.2M | $67.7M | $68.1M | $64.8M | $65.7M |
| Share buybacks | $331.4M | $300.2M | $166.1M | $190.1M | $407.8M |
| Investing cash flow | -$1.67B | -$1.49B | -$872.3M | -$1.78B | -$1.53B |
| Financing cash flow | -$22.6M | $1.97B | $533.5M | $1.20B | $667.6M |
| Net change in cash | -$1.01B | $1.11B | $244.1M | -$86.8M | -$260.2M |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Oct 29, 2026 | 91.3M | −4.2% | SEC |
| Jul 30, 2026 | 92.5M | −4.6% | SEC |
| Apr 30, 2026 | 93.3M | −5.8% | SEC |
| Feb 17, 2026 | 94.3M | −6.5% | SEC |
| Oct 30, 2025 | 95.4M | −7.6% | SEC |
| Jul 30, 2025 | 96.9M | −8.4% | SEC |
| Apr 28, 2025 | 99.1M | −8.4% | SEC |
| Feb 5, 2025 | 100.9M | −7.4% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.